Company
Restor3d
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
22
510(k), De Novo and PMA
Device trials
21
As lead sponsor, any status
Adverse event reports
76
Received Nov 1, 2025 to Nov 20, 2026
Recall records
7
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$197M
5 Form D offerings, 2023 to 2025
Equity
$157M
Stock sold for cash
Debt and convertible notes
$40.4M
$40.4M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $84.8M raised of $94.8M sought, first sale Aug 8, 2025, 133 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Aug 8, 2025 | Equity | $84.8M | $94.8M | 133 | Rule 506(b) | Form D ↗Aug 22, 2025 |
| Jan 15, 2025 | Convertible note | $28.4M | $40.0M | 127 | Rule 506(b) | Form D/A ↗Apr 7, 20253 amendments |
| Jan 22, 2024 | Equity | $55.0M | $55.0M | 150 | Rule 506(b) | Form D/A ↗Jun 13, 20241 amendment |
2 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- RESTOR3D, Inc.
- Headquarters
- Durham, North Carolina
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1723907 ↗
Executives, directors and promoters
As listed on the latest Form D.
11 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Restor3d.
Latest FDA decisions
The 8 newest of 22 since 2015.
- Veritas Shoulder System510(k)
K263421 · Decided Oct 22, 2026 · 27 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
- Veritas Shoulder System510(k)
K260556 · Decided Jul 1, 2026 · 132 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
K253992 · Decided May 7, 2026 · 146 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
19 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- The restor3d Outcomes RegistryRecruiting
NCT07563803 · 2,250 participants (planned) · Start Oct 15, 2026 · Primary completion Oct 15, 2032
Device: Patient-Specific Orthopedic Implant · For: Joint Replacement; Arthropathy
Sites: Durham, North Carolina
- Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM)Enrolling by invitation
NCT06311331 · 50 participants (planned) · Start Nov 6, 2024 · Primary completion Nov 2031
Device: Total Talus Replacement (TTR) · For: Avascular Necrosis of the Talus; Talar Osteochondral Defect of Ankle; Talar Dysfunction
Sites: Charlotte, North Carolina
NCT02494544 · 215 participants · Start Jul 1, 2015 · Primary completion Nov 16, 2022
Device: Off the Shelf Total Knee Replacement; ConforMIS iTotal Knee Replacement · For: Osteoarthritis
Sites: La Jolla, California; San Diego, California; Parker, Colorado · 8 sites in all
18 more trials with a free account
Reports received
76
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
15
20% of reports
Injury reports
61
80% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 2 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 2 | 0 | 0 |
| Feb 25 | 1 | 1 | 0 | 0 |
| Mar 25 | 1 | 1 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 0 | 1 | 0 | 0 |
| Jul 25 | 0 | 3 | 0 | 0 |
| Aug 25 | 2 | 1 | 0 | 0 |
| Sep 25 | 0 | 1 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 6 | 0 | 0 |
| Dec 25 | 0 | 5 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 2 | 1 | 0 | 0 |
| Apr 26 | 1 | 1 | 0 | 0 |
| May 26 | 0 | 7 | 0 | 0 |
| Jun 26 | 2 | 6 | 0 | 0 |
| Jul 26 | 3 | 9 | 0 | 0 |
| Aug 26 | 6 | 14 | 0 | 0 |
| Sep 26 | 1 | 7 | 0 | 0 |
| Oct 26 | 0 | 5 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Veritas Reverse Total Shoulder Replacement, Model/Catalog Number: 3500-140C3, 3500-140U3, 3500-140C1, 3500-140U1, size 1 -2, 40mm Polymer LinerOpen, Classified
Z-0348-2027 · Started Oct 1, 2026 · Posted by FDA Nov 3, 2026
Reason given: (Retroactively reported) Pairing of shoulder implant stem sizes 1 and 2 with the largest glenosphere diameter (40 mm) creates an excessive mechanical loading configuration in which certain polyethylene components lack adequate retention strength, potentially resulting in dislocation, reduced range of motion, or...
Cause as FDA categorized it: Device Design · Device type: Shoulder Prosthesis, Reverse Configuration (PHX)
Z-0264-2027 · Started Sep 4, 2026 · Posted by FDA Oct 22, 2026
Reason given: Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.
Cause as FDA categorized it: Process change control · Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD)
Z-3178-2026 · Started Jul 27, 2026 · Posted by FDA Sep 16, 2026
Reason given: Ankle implantation systems were packaged with incorrect patient-specific cutting guides, which may result in: delayed surgery, the need to use standard instrumentation, reduced fixation or poor alignment of implants, implant loosening/migration, or need for revision surgery.
Cause as FDA categorized it: Labeling Change Control · Device type: Ankle Arthroplasty Implantation System (OYK)
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.